Most Renal Transplant Recipients Were Negative For Multidrug-Resistant Pathogens Shortly After Receiving FMT, With Longer Times To Recurrent Infections, Trial Finds
November 02, 2023
MedPage Today (11/1, Putka) reports, “In the single-center PREMIX clinical trial, most renal transplant recipients were negative for multidrug-resistant pathogens shortly after receiving fecal microbiota transplants (FMT), with longer times to recurrent i...